A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR -tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal transition
Open Access
- 18 August 2017
- journal article
- case report
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 22, 183-186
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancerOncotarget, 2015
- Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase InhibitionCancer Research, 2015
- Shades of T790M: Intratumor Heterogeneity in EGFR-Mutant Lung CancerCancer Discovery, 2015
- Tumour heterogeneity and the evolution of polyclonal drug resistanceMolecular Oncology, 2014
- Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutationsCancer, 2014
- The predictive role of pretreatment epidermal growth factor receptor T790M mutation on the progression-free survival of tyrosine-kinase inhibitor-treated non-small cell lung cancer patients: a meta-analysisOncoTargets and Therapy, 2014
- An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor ResistanceClinical Cancer Research, 2013
- Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destinyCancer and Metastasis Reviews, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2012